Prevalence Of Oral Mucosal Alterations In Diabetes Mellitus Type2

Overview

There are severe deficiency of database concerning the oral health status in Egyptian patients with Diabetes type 2. Our aim in the present study is to study the prevalence of oral mucosal alterations in type 2 DM patients and the effect of hyperglycemia on these alterations in controlled and uncontrolled patients to increase their awareness and minimize all the possible risk factors,to achieve a proper management for all oral problems.

Full Title of Study: “Prevalence Of Oral Mucosal Alterations In a Sample of Egyptian Patients With Diabetes Mellitus Type2: A Hospital Based Cross Sectional Study”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Cross-Sectional
  • Study Primary Completion Date: July 30, 2019

Detailed Description

The study will be held in the Endocrine clinic at El Kasr Al-Ainy Cairo University Hospital for patients with diabetes mellitus type2. The data collected through the questionnaire will be obtained through an interview between the investigator and the patient.Clinical examination will be performed for the oral cavity.Blood sample will be withdrawn from each participant and collected in the clinical pathology lab in El kasr Al Ainy to measure the glycosylated hemoglobin concentration.The salivary gland function will be determined through a small questionnaire and clinical examination of the patient. Selection bias: will be minimized by enrolling the participants in the study in a consecutive order of the entering the clinic. Non-respondent bias: will be minimized by explaining to the participants the aim of the study and their importance and role in the study. Incomplete records: will be excluded from statistical analysis with reporting the cause of not completing the record. Sample size estimation: Based on the previous papers by AL-Maweri,et al ,2013, the prevalence of oral mucosal alterations in diabetic patients 45.1%.Using a precision of 5, a design effect set at 1 with 95% CI (confidence interval), a total sample size of 381 will be sufficient. The sample size was calculated by Epi info.

Arms, Groups and Cohorts

  • controlled diabetic patients
  • uncontrolled diabetic patients

Clinical Trial Outcome Measures

Primary Measures

  • Oral mucosal alterations
    • Time Frame: 10 min
    • Clinical examination according to WHO guidelines by Dichotomous outcome (Yes/No).

Secondary Measures

  • Periodontal condition
    • Time Frame: 10 min
    • Basic periodontal examination by Continuous outcome (Score codes).
  • Salivary glands function
    • Time Frame: 10 min
    • Clinical oral dryness examination and Self estimated questionnaire by Dichotomous outcome (Yes/No).

Participating in This Clinical Trial

Inclusion Criteria

1. Adult patients 2. Patients >25years old 3. Patients diagnosed with diabetes type 2. 4. Egyptian patients. Exclusion Criteria:

1. females diagnosed with gestational diabetes. 2. Patients not physically able to participate in survey or clinical oral examination. 3. Patients with other systemic diseases which may cause oral manifestation as liver disorders. 4. Patients under immunosuppressive drugs. 5. Patients under corticosteriods. 6. Patients with organ transplantation.

Gender Eligibility: All

Minimum Age: 25 Years

Maximum Age: 90 Years

Investigator Details

  • Lead Sponsor
    • Alaa Mahmoud abd El kader
  • Collaborator
    • Cairo University
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Alaa Mahmoud abd El kader, principle investigator, internal resident at oral medicine department – Cairo University
  • Overall Official(s)
    • Mariam fakhr, Study Chair, the Endocrine units at the Kasr Al-Ainy Cairo university hospital.

Citations Reporting on Results

Al-Maweri SA, Ismail NM, Ismail AR, Al-Ghashm A. Prevalence of oral mucosal lesions in patients with type 2 diabetes attending hospital universiti sains malaysia. Malays J Med Sci. 2013 Jul;20(4):39-46.

Bastos AS, Leite AR, Spin-Neto R, Nassar PO, Massucato EM, Orrico SR. Diabetes mellitus and oral mucosa alterations: prevalence and risk factors. Diabetes Res Clin Pract. 2011 Apr;92(1):100-5. doi: 10.1016/j.diabres.2011.01.011. Epub 2011 Mar 3.

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.